Back to Search
Start Over
105 Safety and efficacy of tepotinib in advanced NSCLC patients with MET exon 14 skipping mutation or amplification: a tertiary centre retrospective cohort.
- Source :
-
Lung Cancer (01695002) . 2025 Supplement 1, Vol. 200, pN.PAG-N.PAG. 1p. - Publication Year :
- 2025
- Subjects :
- *NON-small-cell lung carcinoma
*GENETIC mutation
*SAFETY
Subjects
Details
- Language :
- English
- ISSN :
- 01695002
- Volume :
- 200
- Database :
- Academic Search Index
- Journal :
- Lung Cancer (01695002)
- Publication Type :
- Academic Journal
- Accession number :
- 183279487
- Full Text :
- https://doi.org/10.1016/j.lungcan.2025.108215